Columbia University's Zuckerman Institute
Columbia’s Zuckerman Institute is dedicated to sharing the extraordinary research of our scientists with broad audiences.
https://zuckermaninstitute.columbia.edu/
https://zuckermaninstitute.columbia.edu/
COVID-19: Can CoVac-1 Induce Higher SARS-CoV-2-Specific T-Cell Responses Compared to Approved mRNA Vaccines (Pfizer and Moderna) and Vector Vaccines (AstraZeneca)?
By
Columbia University's Zuckerman Institute
FEATURING
Juliane Walz
By
Columbia University's Zuckerman Institute
FEATURING
Juliane Walz
Login to view comments.
Click here to Login
